Sign In
Buy TGTX
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
TG Therapeutics: A Buy For Its Monster Multiple Sclerosis Agent
03:33am, Thursday, 15'th Jun 2023
New earning asset BRIUMVI launched in February and got approved in Europe. BRIUMVI is better than the standard, which already achieved blockbuster status. Better-than-expected sales were generated wit
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
04:28pm, Monday, 01'st May 2023
Biotech stocks were fairly volatile today, thanks to another buyout and a spate of earnings reports. Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics were among the most volatile in t
TG Therapeutics, Inc. (TGTX) Q1 2023 Earnings Call Transcript
01:15pm, Monday, 01'st May 2023
TG Therapeutics, Inc. (NASDAQ:TGTX ) Q1 2023 Earnings Conference Call May 1, 2023 8:30 AM ET Company Participants Mike Weiss - Chairman & CEO Adam Waldman - CCO Sean Power - CFO Jenna Bosco - IR Confe
Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets
12:30pm, Monday, 01'st May 2023
TG Therapeutics more than doubled Wall Street's first-quarter sales expectations on Monday, and TGTX stock rocketed to a five-month high. The post Top 1% Biotech TG Therapeutics Obliterates Bullish Sa
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
09:55am, Monday, 01'st May 2023
TG Therapeutics (TGTX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.51 per share a year ago.
TG Therapeutics to Host Conference Call on First Quarter 2023 Financial Results and Business Update
04:30pm, Friday, 28'th Apr 2023
NEW YORK, April 28, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held on Monday, May 1, 2023, at 8:30 ET to discuss results for the fir
TG Therapeutics: A Plethora Of Good News, Strong Revenues Expected
12:09pm, Friday, 28'th Apr 2023
TG Therapeutics: A Plethora Of Good News, Strong Revenues Expected.
3 Top Biotech Stocks Defying the Bear Market
08:45am, Tuesday, 25'th Apr 2023
TG Therapeutics' MS drug Briumvi has had strong early sales. Viking Therapeutics reports solid clinical results from its obesity drug VK2735.
Get In Now. 7 Stocks That Are Set to Soar.
03:49pm, Thursday, 13'th Apr 2023
While anybody can come up with stocks to buy that may rise over a period of time, predicting which ones will rise imminently represents a whole new ballgame. Allow me to be blunt here: I have zero –
Biotech Stock Surging as Analyst Predicts Strong Sales
03:20pm, Tuesday, 11'th Apr 2023
TG Therapeutics Inc ( NASDAQ:TGTX) stock is on a tear, last seen up 17.7% to trade at $22.38, after yesterday adding 22.8% to for its best single-day percentage gain since December.
Why Shares of TG Therapeutics Soared on Tuesday
01:49pm, Tuesday, 11'th Apr 2023
The company launched multiple sclerosis drug Briumvi on Jan. 26. The drug reportedly has already had nearly $4 million in sales.
TG Therapeutics (TGTX) Surges 22.8%: Is This an Indication of Further Gains?
10:44am, Tuesday, 11'th Apr 2023
TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket
01:23pm, Monday, 10'th Apr 2023
TG Therapeutics' new MS drug, Briumvi, experienced a "solid jump" in March sales, according to a report. TGTX stock flew on Monday.
TG Therapeutics: That ICER Report Doesn't Bother Me
01:25pm, Monday, 20'th Mar 2023
ICER published a report saying TG Therapeutics, Inc.'s briumvi is overpriced. It has said this for other major drugs over the years, with no impact on their bottom lines.
Where TG Therapeutics Stands With Analysts
06:05pm, Wednesday, 01'st Mar 2023 Benzinga
Within the last quarter, TG Therapeutics (NASDAQ:TGTX) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
3
0
1
1
Last
